What ’bout science? [NCA / SHAM]

posted by Helmut Homepage – Vienna, Austria, 2016-02-16 13:12  – Posting: # 15995
Views: 3,323

Hi Jay,

» As mentioned in the EU GL, half of dosage interval may be considered. So if the label states once a day then AUC0-12 and AUC12-last may be considered.

Thank you for repeating what I already have written above.

Do you have an own opinion? I don’t see any pharmacokinetic justification for a cut-off of τ/2 but I’m always eager to learn something new. I can only speculate that the idea of the almighty oracle was to catch with the partial AUCs 50% of the AUC0–τ but that doesn’t work:
kabs/kel  AUC0–τ/2/AUC0–τ  AUCτ/2–τ/AUC0–τ
  2.0         44.4%          55.6%
  1.0         38.0%          62.0%  ⇐ flip-flop
  0.5         34.3%          65.7%

Reminds me on an innovator (!) company which had the splendid idea to develop a new formulation of an antibiotic (doubled strength) in order to “double the time above the MIC”. When I talked about first-order processes and exponential functions and that therefore, this concept could never work they didn’t believe me at first. When I presented some plots they trashed the project. Lack of basic PK knowledge is abundant.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,134 posts in 4,245 threads, 1,386 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 12:53 CET

A Camel is a Horse designed by committee.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5